Grail cuts staff by 30% to focus on blood tests for cancer

Plus: Are ultra-processed foods the tobacco of the 21st century? 

August 16, 2024 Check out STAT+

Sponsored By

Grail STAT+ | Grail announces layoffs as it looks to push forward blood-based cancer detection test The layoffs were announced the same day as its Q2 financial report, its first since it was divested by DNA sequencing juggernaut Illumina in June. By Jonathan Wosen Opinion: Ultra-processed foods: the tobacco of the 21st century? Rise in cancer among people under age 50 correlates to rise in ultra-processed food consumption. FDA should handle UPF like it did tobacco. By Nicholas DeVito The story of the giraffe, its neck, and a possible treatment for human heart disease A Harvard professor is convinced that answers for many of the most vexing human health challenges can be found in the animal kingdom. By Nicholas St. Fleur

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser